SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cambridge Antibody Technology Group
An SI Board Since December 1999
Posts SubjectMarks Bans
625 23 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
25 CAT's Annual Report 1999 is now on line: catplc.co.uk martinJongmans-1/18/2000
24 Dear Michael Murphy: I'm new to the board. I go by Paradigm7241 but everyoparadigm7241-1/16/2000
23 Company Interview Excerpt(TWST):Human antibody drug development technology diffJongmans-1/14/2000
22 Sorry it's not my money at work. I've still got my nose in some paperwomichael_f_murphy-1/13/2000
21 Upward movement continues. Volume also in uptrend martinJongmans-1/13/2000
20 CAT: Strong Upward Movement at High Volume MartinJongmans-1/12/2000
19 <<Many think the patent itself is way too broad as to be enforceable or emichael_f_murphy-1/11/2000
18 Michael, it is indeed a "submarine" patent and a very crucial one. IPseudo Biologist-1/11/2000
17 Re: Kauffman patents </MFM#begin personal opinion> As I read the patent,michael_f_murphy-1/11/2000
16 More info re. possible competition: ixsysinc.com Wonder about the potential oPseudo Biologist-1/8/2000
15 >>undervalued?? Can't really say yet. Just collecting info. Regardmichael_f_murphy-1/7/2000
14 Undervalued now, compared to US Biotechs?! MartinJongmans-1/7/2000
13 Re: Aptein & polysome display (patents & technology) Press release regmichael_f_murphy-1/6/2000
12 Re: Selected cites re IL-12 for my education From CAT annual report: J695 IL-1michael_f_murphy-1/6/2000
11 Re: Medline cites regarding TGFb2 & glaucoma anti-scarring 1 NLM CIT. ID:michael_f_murphy-1/6/2000
10 Re: Medline cites (partial) on TGFbeta2 1 NLM CIT. ID: 99413261 TITLE: A fullmichael_f_murphy-1/6/2000
9 Re: Medline cites regarding D2E7 (BASF clinical trial) 1 NLM CIT. ID: 20046934michael_f_murphy-1/6/2000
8 US 5,885,793 "Production of Anti-Self Antibodies from Antibody Segment Repmichael_f_murphy-1/6/2000
7 Re: LSE:CAT intellectual property The purpose of this subthread is to documentmichael_f_murphy-1/6/2000
6 Excerpts from the 1998 Annual report. 1999 not issued yet. Sorry about the formmichael_f_murphy-1/4/2000
5 Parking some more links for CAT www.bloomberg.co.uk for data on CAT quote.blomichael_f_murphy-1/4/2000
4 Link to www.nasdaq.co.uk for LSE:CAT with news links nasdaq.co.uk Shows recenmichael_f_murphy-1/4/2000
3 Here is a link for the quote on the LSE finance.uk.yahoo.commichael_f_murphy-1/4/2000
2 The stock has been down then flat since 1997 IPO now popping up on news of collmichael_f_murphy-1/4/2000
1 Cambridge Antibody Technology (CAT) website; catplc.co.uk martinJongmans-12/30/1999
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News